Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:1

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:1.)
© 2005 American Heart Association, Inc.

Issue Highlights


*    PERIODONTAL DISEASE AND CORONARY HEART DISEASE: A REAPPRAISAL OF THE EXPOSURE, by Beck et al.
up arrowTop
*PERIODONTAL DISEASE AND CORONARY...
down arrowEFFECTS OF CANDESARTAN ON...
down arrowSTATIN TREATMENT AFTER ONSET...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
There currently is great interest in understanding the role of certain chronic infections as risk factors for cardiovascular disease. In this regard, prior studies have suggested that chronic periodontal disease is associated with increased cardiovascular risk, although it remains possible that the confounding effects of smoking and other classical risk factors explain the association. In this issue of Circulation, Beck and colleagues investigated the relation between periodontal disease and prevalent coronary heart disease in 5002 participants in the fourth examination of the Atherosclerosis Risk in Communities Study. They observed that elevated serum IgG antibodies to several oral pathogens were associated with coronary heart disease, but findings on oral examination were not. Although further prospective studies of this question are needed, the present study suggests that the host response to oral infection may be more important for cardiovascular risk than the local extent of periodontal disease. See p 19.


*    EFFECTS OF CANDESARTAN ON THE DEVELOPMENT OF A NEW DIAGNOSIS OF DIABETES MELLITUS IN PATIENTS WITH HEART FAILURE, by Yusuf et al.
up arrowTop
up arrowPERIODONTAL DISEASE AND CORONARY...
*EFFECTS OF CANDESARTAN ON...
down arrowSTATIN TREATMENT AFTER ONSET...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs) have been associated with a lower incidence of diabetes mellitus in clinical trials of hypertensives and other high-risk patients. However, it is less clear if use of renin-angiotensin axis inhibitors lowers the risk of diabetes in patients with heart failure. In this issue of Circulation, Yusuf and colleagues analyze data from the CHARM trial to assess the risk of developing new-onset diabetes (a prespecified secondary outcome) in more than 5000 heart failure patients randomized to candesartan (an ARB) or placebo. The investigators report that candesartan use was associated with a 22% reduction in incidence of diabetes compared with placebo. The reduction in incidence of diabetes was consistent across clinical subgroups (age, sex, body mass index) and was particularly striking in patients with a relatively preserved ejection fraction. The authors emphasize that use of ARBs in heart failure patients provides added value by lowering the future risk of diabetes. See p 48.


*    STATIN TREATMENT AFTER ONSET OF SEPSIS IN A MURINE MODEL IMPROVES SURVIVAL, by Merx et al.
up arrowTop
up arrowPERIODONTAL DISEASE AND CORONARY...
up arrowEFFECTS OF CANDESARTAN ON...
*STATIN TREATMENT AFTER ONSET...
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
The clinical benefits achieved with HMG-CoA reductase inhibitors have been shown to extend well beyond the recognized lipid-lowering effects of these agents. The pleiotropic effects attributed to statins include increased bioavailable nitric oxide, increased antioxidant properties, inhibition of inflammatory responses, and improvement of endothelial dysfunction. Interestingly, investigators have recognized that these pleiotropic effects may be exploited to offer a therapeutic advantage in clinical situations other than atherothrombotic vascular disease. For example, Merx et al have previously shown that the antiinflammatory effects of statins mediate responses to sepsis; pretreatment with statins improved survival in a murine model of sepsis. In this issue of Circulation, Merx et al extend their previous work and examine the effects of initiating statin therapy after sepsis has been established. These studies may have implications for how clinicians treat sepsis in the future. See p 117.

Visit http://www.circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowPERIODONTAL DISEASE AND CORONARY...
up arrowEFFECTS OF CANDESARTAN ON...
up arrowSTATIN TREATMENT AFTER ONSET...
*Images in Cardiovascular...
down arrowBook Review
down arrowCorrespondence
 
Detection of Luminal-Intimal Border and Coronary Wall Enhancement in Intravascular Ultrasound Imaging After Injection of Microbubbles and Simultaneous Sonication With Transthoracic Echocardiography. See p e1.

Detection of Carotid Atherosclerotic Plaque Ulceration, Calcification, and Thrombosis by Multicontrast Weighted Magnetic Resonance Imaging. See p e3.

Primary Lymphoma of the Heart. See p e5.



View larger version (162K):
[in this window]
[in a new window]
 


*    Book Review
up arrowTop
up arrowPERIODONTAL DISEASE AND CORONARY...
up arrowEFFECTS OF CANDESARTAN ON...
up arrowSTATIN TREATMENT AFTER ONSET...
up arrowImages in Cardiovascular...
*Book Review
down arrowCorrespondence
 
Computed Tomography of the Coronary Arteries. See p e7.


*    Correspondence
up arrowTop
up arrowPERIODONTAL DISEASE AND CORONARY...
up arrowEFFECTS OF CANDESARTAN ON...
up arrowSTATIN TREATMENT AFTER ONSET...
up arrowImages in Cardiovascular...
up arrowBook Review
*Correspondence
 
See p e9.


Related Articles:

Statin Treatment After Onset of Sepsis in a Murine Model Improves Survival
Marc W. Merx, Elisa A. Liehn, Jürgen Graf, Annette van de Sandt, Maren Schaltenbrand, Jürgen Schrader, Peter Hanrath, and Christian Weber
Circulation 2005 112: 117-124. [Abstract] [Full Text]

Detection of Luminal-Intimal Border and Coronary Wall Enhancement in Intravascular Ultrasound Imaging After Injection of Microbubbles and Simultaneous Sonication With Transthoracic Echocardiography
Manolis Vavuranakis, Ioannis A. Kakadiaris, Sean M. O’Malley, Christodoulos Stefanadis, Sophia Vaina, Maria Drakopoulou, Ioannis Mitropoulos, Stephane Carlier, and Morteza Naghavi
Circulation 2005 112: e1-e2. [Full Text]

Detection of Carotid Atherosclerotic Plaque Ulceration, Calcification, and Thrombosis by Multicontrast Weighted Magnetic Resonance Imaging
Baocheng Chu, Marina S. Ferguson, Hunter Underhill, Norihide Takaya, Jianming Cai, Michel Kliot, Chun Yuan, and Thomas S. Hatsukami
Circulation 2005 112: e3-e4. [Full Text]

Primary Lymphoma of the Heart
Jeffrey Kuvin, Nisha Parikh, Robert Salomon, Arthur Tischler, Philip Daoust, Yevgeniy Arshanskiy, Karl Coyner, Philip Carpino, Natesa G. Pandian, Carey Kimmelstiel, Caroline Foote, John Erban, and Hassan Rastegar
Circulation 2005 112: e5-e6. [Full Text]

Computed Tomography of the Coronary Arteries
Frederick L. Ruberg
Circulation 2005 112: e7-e8. [Full Text]

Letter Regarding Article by McNair et al, "SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia" Response
W.A. Groenewegen, A.A.M. Wilde, William P. McNair, Lisa Ku, Matthew R.G. Taylor, Pam R. Fain, Eugene Wolfel, and Luisa Mestroni
Circulation 2005 112: e9-e10. [Full Text]

Periodontal Disease and Coronary Heart Disease: A Reappraisal of the Exposure
James D. Beck, Paul Eke, Gerardo Heiss, Phoebus Madianos, David Couper, Dongming Lin, Kevin Moss, John Elter, and Steven Offenbacher
Circulation 2005 112: 19-24. [Abstract] [Full Text]

Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
Salim Yusuf, Jan B. Ostergren, Hertzel C. Gerstein, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Bertil Olofsson, Jeffrey Probstfield, John V. McMurray on behalf of the Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity Program (CHARM) Investigators
Circulation 2005 112: 48-53. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
R. L. Page II, K. J Utz, and E. E Wolfel
Should {beta}-Blockers Be Used in the Treatment of Cocaine-Associated Acute Coronary Syndrome?
Ann. Pharmacother., December 1, 2007; 41(12): 2008 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S. Venkateswaran and P. Shankar
The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore
Postgrad. Med. J., May 1, 2007; 83(979): 329 - 331.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Cooper, J. D. Cooper, and J. M. Cooper
Cardiopulmonary Resuscitation: History, Current Practice, and Future Direction
Circulation, December 19, 2006; 114(25): 2839 - 2849.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles